Pelitinib

Pelitinib, 257933-82-7, EKB-569, Pelitinib (EKB-569), WAY-EKB 569, EKB 569, WAY-EKB-569, 326894-84-2, (E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, C24H23ClFN5O2, (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, X5DWL380Z6, (2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide, (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide, CHEBI:38927, (E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide, Pelitinib (EKB-569; WAY-EKB 569), MFCD09837868, (E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide, (E)-N-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-3-cyano-7-ethoxy-quinolin-6-yl]-4-(dimethylamino)but-2-enamide, 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, 2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, Pelitinib [USAN], EKI-569, Pelitinib [USAN:INN], UNII-X5DWL380Z6, EKB569, EKI 569, (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, (2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide, 93J, PELITINIB [INN], Pelitinib (USAN/INN), Pelitinib - EKB-569, 2-Butenamide, (E)-,, PELITINIB [WHO-DD], SCHEMBL93756, SCHEMBL93757, MLS006010062, CHEMBL607707, GTPL7644, BDBM31090, cid_6445562, EX-A061, BCPP000118, BCPP000119, BCP02376, NSC729742, NSC800841, s1392, AKOS005146343, CCG-264890, DB05524, NSC-729742, NSC-800841, WAY-172569, NCGC00263103-09, NCGC00263103-10, (E)-N-[4-(3-chloro-4-fluoro-anilino)-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide, AC-24700, AC-25029, AS-16280, HY-32718, SMR004701222, P2529, SW219267-1, EC-000.2259, D05399,

Pelitinib is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate